HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuo Ikebe Selected Research

Vascular Remodeling

5/2014ZIPK is critical for the motility and contractility of VSMCs through the regulation of nonmuscle myosin II isoforms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuo Ikebe Research Topics

Disease

6Fibrosis (Cirrhosis)
04/2022 - 06/2015
3Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2022 - 04/2015
3type 1B Usher syndrome
07/2015 - 05/2009
2Neoplasms (Cancer)
06/2022 - 09/2016
2Empyema
01/2022 - 01/2019
2Inflammation (Inflammations)
10/2021 - 12/2016
2Pneumonia (Pneumonitis)
11/2017 - 03/2016
2Breast Neoplasms (Breast Cancer)
09/2016 - 01/2016
2Lung Injury
03/2016 - 04/2015
2Stroke (Strokes)
09/2009 - 02/2006
2Deafness (Deaf Mutism)
03/2006 - 07/2004
2Portal Hypertension
02/2006 - 05/2004
1Cicatrix (Scar)
01/2022
1Idiopathic Pulmonary Fibrosis
01/2022
1Pleurisy (Pleuritis)
01/2021
1Wounds and Injuries (Trauma)
01/2017
1Usher Syndromes (Usher Syndrome)
01/2017
1Type 2 Diabetes Mellitus (MODY)
10/2016
1Infections
10/2016
1Pulmonary Tuberculosis
10/2016
1Prostatic Neoplasms (Prostate Cancer)
06/2016
1Hyperplasia
06/2016
1Respiratory Tract Infections (Respiratory Tract Infection)
03/2016
1Chronic Obstructive Pulmonary Disease (COPD)
03/2016
1Neoplasm Metastasis (Metastasis)
01/2016
1Lung Diseases (Lung Disease)
04/2015
1Hearing Loss (Hearing Impairment)
07/2014
1Vascular Remodeling
05/2014
1Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl)
12/2009
1Type Ib Usher Syndrome
09/2008
1Hypertension (High Blood Pressure)
02/2008

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
04/2022 - 12/2009
6Myosin VIIaIBA
01/2017 - 03/2006
5Bleomycin (Blenoxane)FDA LinkGeneric
01/2022 - 04/2015
4CollagenIBA
04/2022 - 04/2015
4Myosins (Myosin)IBA
01/2019 - 05/2009
3SootIBA
01/2022 - 06/2015
3Protein Isoforms (Isoforms)IBA
02/2008 - 05/2004
2caveolin-1 (82-101)IBA
03/2022 - 03/2016
2CalponinsIBA
01/2022 - 01/2019
2Plasminogen Activator Inhibitor 1IBA
03/2016 - 04/2015
2Myosin-Light-Chain PhosphataseIBA
02/2008 - 05/2004
1fascinIBA
06/2022
1Fibronectins (Fibronectin)IBA
04/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022
1CateninsIBA
01/2022
1Immune Checkpoint ProteinsIBA
01/2022
1Oxygen (Dioxygen)IBA
10/2021
1ThrombinFDA Link
01/2021
1myocardinIBA
01/2019
1Glycogen Synthase KinasesIBA
11/2017
1Extracellular Matrix ProteinsIBA
01/2017
1Dinoprostone (PGE2)FDA Link
12/2016
1Interleukin-6 (Interleukin 6)IBA
10/2016
1Niacinamide (Nicotinamide)FDA LinkGeneric
10/2016
1CytokinesIBA
10/2016
1Streptozocin (Streptozotocin)FDA Link
10/2016
1Cadherins (E-Cadherin)IBA
09/2016
1VimentinIBA
09/2016
1Mitochondrial DNA (mtDNA)IBA
06/2016
1Electron Transport Complex I (NADH-CoQ Reductase)IBA
06/2016
1Plasminogen Activators (Plasminogen Activator)IBA
03/2016
1Messenger RNA (mRNA)IBA
03/2016
1SmokeIBA
03/2016
1Tumor Suppressor Protein p53IBA
03/2016
1CXC ChemokinesIBA
03/2016
1Interleukin-8B ReceptorsIBA
03/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Cytochromes c (Cytochrome c)IBA
01/2016
1Superoxides (Superoxide)IBA
01/2016
1Peptide Hydrolases (Proteases)FDA Link
06/2015
1Protein Kinases (Protein Kinase)IBA
05/2014
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
02/2008
1Adenosine Triphosphate (ATP)IBA
02/2006
1Adenosine Diphosphate (ADP)IBA
07/2004
1myosin VIIBA
07/2004

Therapy/Procedure

1Ligation
05/2004